Anika Therapeutics (ANIK) Earnings Date, Estimates & Call Transcripts → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free ANIK Stock Alerts $25.63 +0.37 (+1.46%) (As of 05/10/2024 08:54 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (Mar. 13) $0.05 Beat By $0.20 Consensus EPS (Mar. 13) -$0.15 Get Anika Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ANIK and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueANIK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANIK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. Anika Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241($0.28)($0.28)($0.28) Q2 20241$0.23$0.23$0.23 Q3 20241$0.34$0.34$0.34 Q4 20241$0.43$0.43$0.43 FY 20244$0.72$0.72$0.72 Q1 20251$0.22$0.22$0.22 Q2 20251$0.26$0.26$0.26 Q3 20251$0.39$0.39$0.39 Q4 20251$0.44$0.44$0.44 FY 20254$1.31$1.31 $1.31ANIK Earnings Date and InformationAnika Therapeutics last released its earnings results on March 13th, 2024. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.20. The company had revenue of $42.97 million for the quarter, compared to the consensus estimate of $41.51 million. Anika Therapeutics has generated ($5.25) earnings per share over the last year (($5.25) diluted earnings per share). Earnings for Anika Therapeutics are expected to grow by 22.22% in the coming year, from $1.08 to $1.32 per share. Anika Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Anika Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024Estimated)------- 3/13/2024Q4 2023($0.15)$0.05+$0.20$4.40$41.51 million$42.97 million8/8/2023Q2 2023($0.27)($0.06)+$0.21$0.07$40.61 million$44.30 million5/9/2023Q1 2023($0.29)($0.36)($0.07)($0.01)$37.16 million$37.92 million3/6/2023Q4 2022($0.15)($0.21)($0.06)($0.08)$38.32 million$39.62 million11/8/2022Q3 2022($0.18)($0.05)+$0.13$0.19$36.56 million$40.26 million8/3/2022Q2 2022($0.19)($0.12)+$0.07($0.04)$36.40 million$39.66 million Get the Latest News and Ratings for ANIK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anika Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/5/2022Q1 2022($0.24)($0.11)+$0.13($0.02)$33.90 million$36.69 million 3/8/2022Q4 2021-($0.23)($0.23)($0.06)$32.85 million$35.82 million 11/4/2021Q3 2021($0.21)$0.05+$0.26$0.06$36.45 million$39.54 million 8/4/2021Q2 2021($0.15)$0.45+$0.60($0.27)$34.51 million$38.15 million Anika Therapeutics Earnings - Frequently Asked Questions When is Anika Therapeutics's earnings date? Anika Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on ANIK's earnings history. Did Anika Therapeutics beat their earnings estimates last quarter? In the previous quarter, Anika Therapeutics (NASDAQ:ANIK) reported $0.05 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.15) by $0.20. Learn more on analysts' earnings estimate vs. ANIK's actual earnings. How much revenue does Anika Therapeutics generate each year? Anika Therapeutics (NASDAQ:ANIK) has a recorded annual revenue of $166.66 million. How much profit does Anika Therapeutics generate each year? Anika Therapeutics (NASDAQ:ANIK) has a recorded net income of -$82.67 million. ANIK has generated -$5.25 earnings per share over the last four quarters. What is Anika Therapeutics's price-to-earnings ratio? Anika Therapeutics (NASDAQ:ANIK) has a forward price-to-earnings ratio of 23.73. The price/earnings-to-growth ratio is 2.37. What is Anika Therapeutics's EPS forecast for next year? Anika Therapeutics's earnings are expected to grow from $1.08 per share to $1.32 per share in the next year, which is a 22.22% increase. More Earnings Resources from MarketBeat Related Companies: OSUR Earnings CERS Earnings UTMD Earnings ATRI Earnings SKIN Earnings PLSE Earnings BVS Earnings NVRO Earnings NPCE Earnings SRDX Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:ANIK) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupThis 1 Biotech Stock has been shocking the marketsHuge AlertsDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorBill Clinton Backing Biden Replacement???The Freeport SocietyThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
